| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ai Goto, Ryuichi Kambayashi, Hiroko Izumi-Nakaseko, Yoshinori Takei, Atsushi Sugiyam. β-Adrenoceptor blockade can augment the torsadogenic action of risperidone. Journal of pharmacological sciences. vol 156. issue 2. 2024-08-23. PMID:39179332. |
risperidone is a second-generation antipsychotic for treating schizophrenia and bipolar disorder. |
2024-08-23 |
2024-08-27 |
Not clear |
| Mohammad-Ali Samizadeh, Seyedeh-Tabassom Abdollahi-Keyvani, Hamed Fallah, Bahar Beigi, Atefeh Motamedi-Manesh, Sogand Adibian, Salar Vasegh. Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine. Journal of psychiatric research. vol 178. 2024-08-15. PMID:39146821. |
on the other hand, risperidone is a potent antipsychotic medication that is approved for the treatment of schizophrenia and bipolar disorder. |
2024-08-15 |
2024-08-18 |
rat |
| Justin Faden, Camila Ramirez, Vanessa Martinez, Leslie Citrom. An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder. Expert review of neurotherapeutics. 2024-07-24. PMID:39044342. |
an overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder. |
2024-07-24 |
2024-07-26 |
Not clear |
| Dhouha Sahnoun, Ahlem Ghanmi, Soumaya Gazzeh, Bochra Saguem, Raoudha Slim, Jaafar Nakhli, Chaker Ben Sale. Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature. Pharmacopsychiatry. vol 57. issue 2. 2024-03-12. PMID:38471512. |
risperidone, less commonly associated with hematologic adverse effects, is an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and irritability associated with autism. |
2024-03-12 |
2024-03-15 |
Not clear |
| Faezeh Khorshidian, Angela Hamidia, Farzan Kheirkhah, Ali Akbar Moghadamnia, Ali Bijani, Seyedeh Mahbobeh Mirtabar, Sakineh Javadian Koutanae. Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive-compulsive disorder in patients with bipolar disorder: Double-blind, randomized clinical trial. Health science reports. vol 6. issue 8. 2023-08-30. PMID:37645033. |
comparison of aripiprazole and risperidone effectiveness in treating obsessive-compulsive disorder in patients with bipolar disorder: double-blind, randomized clinical trial. |
2023-08-30 |
2023-09-07 |
Not clear |
| Janusz K Rybakowsk. Application of Antipsychotic Drugs in Mood Disorders. Brain sciences. vol 13. issue 3. 2023-03-29. PMID:36979224. |
the second-generation, so-called atypical antipsychotics (sgas), such as clozapine, risperidone, olanzapine, and quetiapine, have antimanic activity and are also effective for the maintenance treatment of bipolar disorder. |
2023-03-29 |
2023-08-14 |
human |
| Alexander Hodkinson, Carl Heneghan, Kamal R Mahtani, Evangelos Kontopantelis, Maria Panagiot. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. BMC medicine. vol 19. issue 1. 2021-10-15. PMID:34429113. |
benefits and harms of risperidone and paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. |
2021-10-15 |
2023-08-13 |
human |
| Alexander Hodkinson, Carl Heneghan, Kamal R Mahtani, Evangelos Kontopantelis, Maria Panagiot. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. BMC medicine. vol 19. issue 1. 2021-10-15. PMID:34429113. |
as existing evidence on both antipsychotics are solely based on aggregate data, we aimed to assess the benefits and harms of risperidone and paliperidone in the treatment of patients with schizophrenia or bipolar disorder, using individual participant data (ipd), clinical study reports (csrs) and publicly available sources (journal publications and trial registries). |
2021-10-15 |
2023-08-13 |
human |
| Sanjay Prakash, Deepali Lodha, Kalu Singh Rawa. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist? BMJ case reports. vol 14. issue 8. 2021-08-18. PMID:34400419. |
we report a 21-year-old man with bipolar disorder who was on a stable dose of escitalopram and risperidone. |
2021-08-18 |
2023-08-13 |
Not clear |
| Liroy Lugasi, Igor Grinberg, Rivka Sabag, Ravit Madar, Haim Einat, Shlomo Marge. Proteinoid Nanocapsules as Drug Delivery System for Improving Antipsychotic Activity of Risperidone. Molecules (Basel, Switzerland). vol 25. issue 17. 2021-03-10. PMID:32887463. |
risperidone (rsp) is an atypical antipsychotic drug widely used to treat schizophrenia and bipolar disorder. |
2021-03-10 |
2023-08-13 |
mouse |
| Hossein Sanjari Moghaddam, Soya Bahmani, Samaneh Bayanati, Mahsa Mahdavinasa, Farzin Rezaei, Shahin Akhondzade. Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial. International clinical psychopharmacology. vol 35. issue 2. 2021-01-15. PMID:31743233. |
this is a double-blind, placebo-controlled, parallel-grouped clinical trial, which was designed to investigate the potential effects of melatonin add-on treatment with lithium and risperidone on acute manic episodes in patients with bipolar disorder (bd). |
2021-01-15 |
2023-08-13 |
human |
| Megan Beauchemin, Ramaz Geguchadze, Anyonya R Guntur, Kathleen Nevola, Phuong T Le, Deborah Barlow, Megan Rue, Calvin P H Vary, Christine W Lary, Katherine J Motyl, Karen L Houseknech. Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice. Pharmacological research. vol 152. 2020-12-31. PMID:31874253. |
atypical antipsychotic (aa) medications including risperidone (ris) and olanzapine (olan) are fda approved for the treatment of psychiatric disorders including schizophrenia, bipolar disorder and depression. |
2020-12-31 |
2023-08-13 |
mouse |
| Yang Liu, Jun Liang, Qingrong Xia, Xin Zhou, Xuefeng Xi. Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China. Neuropsychiatric disease and treatment. vol 16. 2020-11-13. PMID:33177826. |
to explore the therapeutic effects of lithium combined with second-generation antipsychotics (sgas) of quetiapine, clozapine, olanzapine, and risperidone for the treatment of manic episodes in patients with bipolar disorder (bd) to guide the selection of medications. |
2020-11-13 |
2023-08-13 |
Not clear |
| Konstantinos N Fountoulakis, Ioannis Nimatoudis, Apostolos Iacovides, George Kaprini. Off-label indications for atypical antipsychotics: A systematic review. Annals of general hospital psychiatry. vol 3. issue 1. 2020-09-30. PMID:14975068. |
material and method: medline was searched with the combination of each one of the key words: risperidone, olanzapine and quetiapine with key words that refered to every dsm-iv diagnosis other than schizophrenia and other psychotic disorders, bipolar disorder and dementia and memory disorders. |
2020-09-30 |
2023-08-12 |
Not clear |
| Sevcan Karakoç Demirkaya, Süleyman Salih Zoroğl. Long-acting Injectable Risperidone Use in an 11-Years-Old Bipolar Child. Noro psikiyatri arsivi. vol 53. issue 4. 2020-09-30. PMID:28360814. |
risperidone is a commonly used atypical antipsychotic it has been approved for the treatment of manic and mixed episodes of bipolar disorder even in 10-17-year-old patients, and it is commonly used. |
2020-09-30 |
2023-08-13 |
Not clear |
| Sadhana Holla, M B Amberkar, Avinash Kamath, Meena Kumari Kamalkishore, Balaji Ommuruga. Risperidone Induced Granulomatous Mastitis Secondary to Hyperprolactinemia in a Non-Pregnant Woman-A Rare Case Report in a Bipolar Disorder. Journal of clinical and diagnostic research : JCDR. vol 11. issue 1. 2020-09-29. PMID:28273980. |
risperidone induced granulomatous mastitis secondary to hyperprolactinemia in a non-pregnant woman-a rare case report in a bipolar disorder. |
2020-09-29 |
2023-08-13 |
Not clear |
| Serkan Güneş, Özalp Ekinci, Halenur Teke, Veli Yıldırı. Risperidone Related Raynaud's Phenomenon: An Adolescent Case. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 16. issue 1. 2020-09-29. PMID:29397675. |
in children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. |
2020-09-29 |
2023-08-13 |
Not clear |
| Marie Tournier, Anke Neumann, Elodie Pambrun, Alain Weill, Jean-Philippe Chaffiol, François Alla, Bernard Bégaud, Géric Maura, Hélène Verdou. Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure. Journal of affective disorders. vol 257. 2020-06-29. PMID:31306992. |
the study compared treatment failure when using three therapeutic strategies in bipolar disorders: (i) mood stabilizers (mss: lithium, valpromide, divalproate, carbamazepine, lamotrigine) without second-generation antipsychotic (sgap); (ii) sgaps (aripiprazole, olanzapine, risperidone, quetiapine) without ms; (iii) combination of mss and sgaps. |
2020-06-29 |
2023-08-13 |
Not clear |
| Meghan May, Megan Beauchemin, Calvin Vary, Deborah Barlow, Karen L Houseknech. The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice. PloS one. vol 14. issue 6. 2020-02-18. PMID:31242264. |
atypical antipsychotic medications such as risperidone are widely prescribed for diverse psychiatric indications including schizophrenia, bipolar disorder and depression. |
2020-02-18 |
2023-08-13 |
mouse |
| Kimberly Clinebell, Jessica Gannon, Sarah Debrunner, K N Roy Chengapp. Long-acting risperidone injections in a pregnant patient with bipolar disorder. Bipolar disorders. vol 19. issue 7. 2019-11-20. PMID:29120507. |
long-acting risperidone injections in a pregnant patient with bipolar disorder. |
2019-11-20 |
2023-08-13 |
Not clear |